These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 21721852)
1. Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin. Ruan Y; Yao L; Zhang B; Zhang S; Guo J Drug Dev Ind Pharm; 2012 Jan; 38(1):123-8. PubMed ID: 21721852 [TBL] [Abstract][Full Text] [Related]
2. Antinociceptive properties of nasal delivery of neurotoxin-loaded nanoparticles coated with polysorbate-80. Ruan Y; Yao L; Zhang B; Zhang S; Guo J Peptides; 2011 Jul; 32(7):1526-9. PubMed ID: 21600257 [TBL] [Abstract][Full Text] [Related]
3. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier]. Zhao YM; Xia AX; Wei YH; Ruan YP; Li FZ Yao Xue Xue Bao; 2010 Oct; 45(10):1312-6. PubMed ID: 21348312 [TBL] [Abstract][Full Text] [Related]
4. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats. Zhang X; Liu L; Chai G; Zhang X; Li F Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853 [TBL] [Abstract][Full Text] [Related]
5. [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles]. Aliautdin RN; Petrov VE; Langer K; Berthold A; Kreuter J; Kharkevich DA Eksp Klin Farmakol; 1998; 61(1):17-20. PubMed ID: 9575405 [TBL] [Abstract][Full Text] [Related]
6. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095 [TBL] [Abstract][Full Text] [Related]
7. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. Rempe R; Cramer S; Hüwel S; Galla HJ Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier. Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104 [TBL] [Abstract][Full Text] [Related]
9. Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study. Cheng Q; Feng J; Chen J; Zhu X; Li F Biopharm Drug Dispos; 2008 Nov; 29(8):431-9. PubMed ID: 18837064 [TBL] [Abstract][Full Text] [Related]
11. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351 [TBL] [Abstract][Full Text] [Related]
12. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Gao K; Jiang X Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779 [TBL] [Abstract][Full Text] [Related]
13. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration. Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752 [TBL] [Abstract][Full Text] [Related]
14. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165 [TBL] [Abstract][Full Text] [Related]
15. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105 [TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106 [TBL] [Abstract][Full Text] [Related]
17. In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles. Liu H; Ni J; Wang R Pharmazie; 2006 May; 61(5):450-2. PubMed ID: 16724544 [TBL] [Abstract][Full Text] [Related]
18. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. Geldenhuys W; Mbimba T; Bui T; Harrison K; Sutariya V J Drug Target; 2011 Nov; 19(9):837-45. PubMed ID: 21692650 [TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255 [TBL] [Abstract][Full Text] [Related]
20. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]